Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00357825
Status:
COMPLETED
Last Update Posted:
2013-05-15
First Post:
2006-07-26
Brief Title:
A Trial Assessing The Effectiveness and Safety of SS-Reboxetine in Patients With Fibromyalgia
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
An 8-Week Randomized Double-Blind Placebo-Controlled Multi-Centre Study of SS-Reboxetine Administered Once Daily in Patients With Fibromyalgia
Status:
COMPLETED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the safety and effectiveness of SS-Reboxetine in patients with fibromyalgia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None